Everything PR News
PR News

New FDA Cigarette Warning Labels Are Larger, More Prominent

Editorial TeamBy Editorial Team1 min read
New FDA Cigarette Warning Labels Are Larger, More Prominent
Share
The American Food and Drug Administration (FDA) hopes that the new cigarette warning labels scheduled to replace the commonly known graphic representations of illnesses caused by smoking on current packs beginning September 2012 will have a significant public health impact. The FDA strongly believes that graphic images help decreasing the number of smokers, and as a result, have a considerable impact on population life expectancy. Thus, a new set of images has been designed to reflect FDA's commitment to saving lives. The image featured on the right is already a classic, and none of the other graphics in the batch show more creativity. A perfect example of size doesn't equal quality. Larger doesn't mean better in this case. Repeating the same message over and over, obsessively, may have an impact on some, while others will probably ignore the graphics: addictions are always stronger than doctor's orders. The final FDA set of cigarette health warnings contains nine different text warnings and accompanying color graphics to increase awareness of the specific health risks associated with smoking, such as death, addiction, lung disease, cancer, stroke and heart disease; to encourage smokers to quit; and to inspire youth to say no to tobacco. Starting in September 2012, the new cigarette health warnings will appear on the top 50 percent of both the front and rear panels of each cigarette package, and in the upper portion of each cigarette advertisement, occupying at least 20 percent of the area of the advertisement. And this is how cigarette package designers are out of jobs. One last note: beginning October 2012, cigarette manufacturers can no longer distribute cigarettes for sale in the United States unless they display the new cigarette health warnings. Of course, they will comply.
Editorial Team
Written by
Editorial Team

The Everything-PR Editorial Team produces reporting, research, and analysis across thirty verticals — communications, reputation, AI visibility, public affairs, media systems, and digital discovery in the answer-engine era. Publishing since 2009.

Other news

See all
How AI Platform Detection Changes Enterprise AI Buying
Editorial Team · 05/24/2026

How AI Platform Detection Changes Enterprise AI Buying

An enterprise AI procurement cycle after Hermes is a governance conversation. The capability questions still matter. They no longer differentiate. The questions that differentiate are now about what the platform reads, what it decides, and what happens when it gets the decision wrong. This piece is the operational guide to how that shift changes procurement, what to add to every RFP, and where to push back.

Status Labs: Executive Reputation Management in the Era of AI Search
Editorial Team · 05/24/2026

Status Labs: Executive Reputation Management in the Era of AI Search

Status Labs, founded in 2012, is a prominent online reputation management and digital marketing firm. Known for elevating positive content to manage search results, the company is now pivoting to address the impact of AI chatbots on executive reputation. The firm has a history that includes both significant success and notable controversies, making its current adaptation a key case study in the evolving reputation management industry.

When Multicultural Marketing Works, It Doesn’t Look Like Marketing at All
Editorial Team · 05/24/2026

When Multicultural Marketing Works, It Doesn’t Look Like Marketing at All

The most effective multicultural marketing in 2026 feels like culture, not marketing. Brands must move beyond surface-level inclusion to engage deeply with diverse audiences through cultural fluency, community-led storytelling, and relevant influencer partnerships. This approach drives innovation and cultural impact, making marketing disappear into the fabric of culture, rather than just being visible.

Never Miss a Headline

Daily PR headlines, weekly long-form analysis, and our proprietary research drops — straight to your inbox.